Gas Chromatography Mass Spectrometry (GC‐MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine
暂无分享,去创建一个
[1] J. A. Hopper,et al. Designer drugs 2015: assessment and management , 2015, Addiction Science & Clinical Practice.
[2] D. Barceloux,et al. Disposition of Toxic Drugs and Chemicals in Man , 2015 .
[3] K. Kuwayama,et al. Analysis of 4‐Bromo‐2,5‐DimethoxyphenethylamineAbuser's Urine: Identification and Quantitation of Urinary Metabolites , 2013, Journal of forensic sciences.
[4] T. Kanamori,et al. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. , 2002, Journal of analytical toxicology.
[5] J. Veuthey,et al. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market. , 1998, Journal of analytical toxicology.
[6] T. Kwong. The clinical toxicology laboratory : contemporary practice of poisoning evaluation , 2013 .
[7] J. Deruiter,et al. GC-MS and GC-IRD studies on dimethoxyphenethylamines (DMPEA): regioisomers related to 2,5-DMPEA. , 2012, Journal of chromatographic science.
[8] Rie Ito,et al. Analysis of Drugs of Abuse in Biological Specimens , 2011 .
[9] Kelly C. Lee,et al. Urine drug screening: practical guide for clinicians. , 2008, Mayo Clinic proceedings.